Comparison of enzyme-linked immunosorbent assay, Western blotting, microagglutination, indirect immunofluorescence assay, and flow cytometry for serological diagnosis of tularemia

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 6, 2004, Pages 1008-1015

  Porsch Özcürümez, Mustafa ^a   Kischel, Nele ^a   Priebe, Heidi ^a   Splettstösser, Wolf ^a   Finke, Ernst Jürgen ^a   Grunow, Roland ^a  

^a BUNDESWEHR INSTITUTE OF MICROBIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTINATION TEST; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FRANCISELLA TULARENSIS; HUMAN; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; NONHUMAN; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; TULAREMIA; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; FEMALE; FRANCISELLA TULARENSIS; HUMANS; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TULAREMIA;

EID: 9144254654     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.6.1008-1015.2004     Document Type: Article

References (39)

1. Aronova, N. V., and N. V. Pavlovich. 2001. Comparative analysis of the immune response of a rabbit to antigens to live and killed Francisella species bacteria. Mol. Gen. Mikrobiol. Virusol. 2001:26-30. (In Russian.)
2. Behan, K. A., and G. C. Klein. 1982. Reduction of Brucella species and Francisella tularensis cross-reacting agglutinins by dithiothreitol. J. Clin. Microbiol. 16:756-757.
3. Bellach, B. M., H. Knopf, and W. Thefeld. 1998. The German Health Survey, 1997/98. Gesundheitswesen 60(Suppl. 2):S59-S68. (In German.)
4. Berdal, B. P., R. Mehl, H. Haaheim, M. Loksa, R. Grunow, J. Burans, C. Morgan, and H. Meyer. 2000. Field detection of Francisella tularensis. Scand. J. Infect. Dis. 32:287-291.
5. Bevanger, L., J. A. Maeland, and A. I. Kvan. 1994. Comparative analysis of antibodies to Francisella tularensis antigens during the acute phase of tularemia and eight years later. Clin. Diagn. Lab. Immunol. 1:238-240.
6. Bevanger, L., J. A. Maeland, and A. I. Naess. 1988. Agglutinins and antibodies to Francisella tularensis outer membrane antigens in the early diagnosis of disease during an outbreak of tularemia. J. Clin. Microbiol. 26:433-437.
7. Bevanger, L., J. A. Maeland, and A. I. Naess. 1989. Competitive enzyme immunoassay for antibodies to a 43,000-molecular-weight Francisella tularensis outer membrane protein for the diagnosis of tularemia. J. Clin. Microbiol. 27:922-926.
8. Bhatti, A. R., J. P. Wong, and D. E. Woods. 1993. Production and partial characterization of hybridoma clones secreting monoclonal antibodies against Francisella tularensis. Hybridoma 12:197-202.
9. Billings, A. N., J. A. Rawlings, and D. H. Walker. 1998. Tick-borne diseases in Texas: a 10-year retrospective examination of cases. Tex. Med. 94:66-76.
10. Burke, D. S. 1977. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J. Infect. Dis. 135:55-60.
11. Carlsson, H. E., A. A. Lindberg, G. Lindberg, B. Hederstedt, K. A. Karlsson, and B. O. Agell. 1979. Enzyme-linked immunosorbent assay tor immunological diagnosis of human tularemia. J. Clin. Microbiol. 10:615-621.
12. Cerny, Z. 1991. Group immunity against tularemia in employees of the Zelenina Processing Plant in Brno. Cesk. Epidemiol. Mikrobiol. Imunol. 40:193-203. (In Czech.)
13. Conlan, J. W., H. Shen, A. Webb, and M. B. Perry. 2002. Mice vaccinated with the O-antigen of Francisella tularensis LVS lipopolysaccharide conjugated to bovine serum albumin develop varying degrees of protective immunity against systemic or aerosol challenge with virulent type A and type B strains of the pathogen. Vaccine 20:3465-3471.
14. Deutz, A., K. Fuchs, W. Schuller, N. Nowotny, H. Auer, H. Aspock, D. Stunzner, U. Kerbl, C. Klement, and J. Kofer. 2003. Seroepidemiological studies of zoonotic infections in hunters in southeastern Austria - prevalences, risk factors, and preventive methods. Berl. Munch. Tierarztl. Wochenschr. 116:306-311. (In German.)
15. Ellis, J., P. C. Oyston, M. Green, and R. W. Titball. 2002. Tularemia. Clin. Microbiol. Rev. 15:631-646.
16. Ericsson, M., G. Sandstrom, A. Sjostedt, and A. Tarnvik. 1994. Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J. Infect. Dis. 170:110-114.
17. Ericsson, M., A. Tarnvik, K. Kuoppa, G. Sandstrom, and A. Sjostedt. 1994. Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect. Immun. 62:178-183.
18. Feldman, K. A., D. Stiles-Enos, K. Julian, B. T. Matyas, S. R. Telford III, M. C. Chu, L. R. Petersen, and E. B. Hayes. 2003. Tularemia on Martha's Vineyard: seroprevalence and occupational risk. Emerg. Infect. Dis. 9:350-354.
19. Frolich, K., J. Wisser, H. Schmuser, U. Fehlberg, H. Neubauer, R. Grunow, K. Nikolaou, J. Priemer, S. Thiede, W. J. Streich, and S. Speck. 2003. Epizootiologic and ecologic investigations of European brown hares (Lepus europaeus) in selected populations from Schleswig-Holstein, Germany. J. Wildl. Dis. 39:751-761.
20. Fulop, M. J., T. Webber, R. J. Manchee, and D. C. Kelly. 1991. Production and characterization of monoclonal antibodies directed against the lipopolysaccharide of Francisella tularensis. J. Clin. Microbiol. 29:1407-1412.
21. Greiser-Wilke, I., C. Soine, and V. Moennig. 1989. Monoclonal antibodies reacting specifically with Francisella sp. Zentbl. Veterinarmed. B 36:593-600.
22. Grunow, R., W. Splettstoesser, S. McDonald, C. Otterbein, T. O'Brien, C. Morgan, J. Aldrich, E. Hofer, E. J. Finke, and H. Meyer. 2000. Detection of Francisella tularensis in biological specimens using a capture enzyme-linked immunosorbent assay, an immunochromatographic handheld assay, and a PCR. Clin. Diagn. Lab. Immunol. 7:86-90.
23. Gurycova, D., V. Vyrostekova, G. Khanakah, E. Kocianova, and G. Stanek. 2001. Importance of surveillance of tularemia natural foci in the known endemic area of Central Europe, 1991-1997. Wien. Klin. Wochenschr. 113:433-438.
24. Gutierrez, M. P., M. A. Bratos, J. I. Garrote, A. Duenas, A. Almaraz, R. Alamo, M. H. Rodriguez, M. J. Rodriguez Recio, M. F. Munoz, A. Orduna, and A. Rodriguez-Torres. 2003. Serologic evidence of human infection by Francisella tularensis in the population of Castilia y Leon (Spain) prior to 1997. FEMS Immunol. Med. Microbiol. 35:165-169.
25. Junhui, Z., Y. Ruifu, L. Jianchun, Z. Songle, C. Meiling, C. Fengxiang, and C. Hong. 1996. Detection of Francisella tularensis by the polymerase chain reaction. J. Med. Microbiol. 45:477-482.
26. Kamennova, L. S., V. I. Pokrovskaia, V. P. Vasil'eva, L. I. Petrova, and V. B. Liubomudrov. 1983. Comparative study of the basic immunological reactions for assessing tularemia immunity in inoculated persons or those who have had the disease. Zh. Mikrobiol. Epidemiol. Immunobiol. 11:92-95. (In Russian.)
27. Koskela, P., and E. Herva. 1982. Immunity against Francisella tularensis in northern Finland. Scand. J. Infect. Dis. 14:195-199.
28. Koskela, P., and A. Salminen. 1985. Humoral immunity against Francisella tularensis after natural infection. J. Clin. Microbiol. 22:973-979.
29. Long, G. W., J. J. Oprandy, R. B. Narayanan, A. H. Fortier, K. R. Porter, and C. A. Nacy. 1993. Detection of Francisella tularensis in blood by polymerase chain reaction. J. Clin. Microbiol. 31:152-154.
30. Metz, C. E. 1978. Basic principles of ROC analysis. Semin. Nuclear Med. 8:283-298.
31. Reintjes, R., I. Dedushaj, A. Gjini, T. R. Jorgensen, B. Cotter, A. Lieftucht, F. D'Ancona, D. T. Dennis, M. A. Kosoy, G. Mulliqi-Osmani, R. Grunow, A. Kalaveshi, L. Gashi, and I. Humolli. 2002. Tularemia outbreak investigation in Kosovo: case control and environmental studies. Emerg. Infect. Dis. 8:69-73.
32. Sandstrom, G., A. Sjostedt, T. Johansson, K. Kuoppa, and J. C. Williams. 1992. Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol. Immunol. 5:201-210.
33. Sato, T., H. Fujita, Y. Ohara, and M. Homma. 1990. Microagglutination test for early and specific serodiagnosis of tularemia. J. Clin. Microbiol. 28:2372-2374.
34. Schmid, G. P., A. N. Kornblatt, C. A. Conoors, C. Patton, J. Carney, J. Hobbs, and A. F. Kaufmann. 1983. Clinically mild tularemia associated with tick-borne Francisella tularensis. J. Infect. Dis. 148:63-67.
35. Sjostedt, A., U. Eriksson, L. Berglund, and A. Tarnvik. 1997. Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J. Clin. Microbiol. 35:1045-1048.
36. Splettstoesser, W. D., R. Grunow, L. Rahalison, T. J. Brooks, S. Chanteau, and H. Neubauer. 2003. Serodiagnosis of human plague by a combination of immunomagnetic separation and flow cytometry. Cytometry 53A:88-96.
37. Viljanen, M. K., T. Nurmi, and A. Salminen. 1983. Enzyme-linked immunosorbent assay (ELISA) with bacterial sonicate antigen for IgM, IgA, and IgG antibodies to Francisella tularensis: comparison with bacterial agglutination test and ELISA with lipopolysaccharide antigen. J. Infect. Dis. 148:715-720.
38. Vyrostekova, V., G. Khanakah, E. Kocianova, D. Gurycova, and G. Stanek. 2002. Prevalence of coinfection with Francisella tularensis in reservoir animals of Borrelia burgdorferi sensu lato. Wien. Klin. Wochenschr. 114:482-488.
39. Zweig, M., and G. Campbell. 1993. Receiver operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:561-577.